Alain Prochiantz is a prominent figure in the field of molecular biology, serving as the Co-founder and Chief Scientific Officer at BrainEver since 2015, where they focus on developing novel therapeutic agents for neurodegenerative diseases. They completed a PhD thesis on plant messenger RNAs, went on to lead significant research on neural development at Collège de France, and chaired the Biology Department there. Alain has also held professorships and leadership roles at several prestigious institutions, including Ecole Normale Supérieure and the French Academy of Sciences, contributing extensively to the understanding of neuronal polarity and intercellular signaling.
This person is not in any teams
This person is not in any offices